Treatment for IgE-mediated disease

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9707279
SERIAL NO

14002949

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides an EndoS polypeptide, or a polynucleotide encoding an EndoS polypeptide, for use in a method for treating or preventing a disease or condition mediated by IgE antibodies.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HANSA BIOPHARMA AB220 07 LUND

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Allhorn, Maria Ramlosa, SE 4 30
Carlstrom, Karl Hok, SE 1 2
Collin, Mattias Lund, SE 6 40
Lood, Rolf New York, US 7 11
Nimmerjahn, Falk Erlangen, DE 23 135
Sjogren, Jonathan Lund, SE 1 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 18, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 18, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00